Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
11/2008
11/27/2008US20080292589 Novel heterocyclic substituted pyridine or phenyl compounds with cxcr3 antagonist activity
11/27/2008US20080292588 hepatitis C virus; 5-(4-fluoro-benzyl)-8-hydroxy-7-(1-methyl-1 oxo-1 lambda 6-benzo[1,2,4]thiadiazin-3-yl)-5-aza-spiro[2.5]oct-7-en-6-one
11/27/2008US20080292585 Azonafide Derivatives, Methods for Their Production and Pharmaceutical Compositions Therefrom
11/27/2008US20080292584 Metaxalone products, method of manufacture, and method of use
11/27/2008US20080292583 Methods for treating multiple myeloma using 3-(4-amino-1-oxo-1,3-dihydroindol-2-yl)-piperidine-2,6-dione following autologous stem cell transplantation
11/27/2008US20080292582 imidazole derivatives; Alzheimer's Disease, Down syndrome and Huntington's Disease; hypotensive agents; sleeping and eating disorders, anxiolytic agents, antidepressants, antiepileptic agents; drug abuse/withdrawl; 1-(3,4-dimethoxyphenyl)-3-(3-(5-methyl-1H-imidazol-1-yl)propyl)thiourea
11/27/2008US20080292580 Treatment of Inflammatory Diseases
11/27/2008US20080292579 Polymer-Based Serum Albumin Substitute
11/27/2008US20080292568 3-Deoxyglucosone and skin
11/27/2008US20080292566 Oral composition containing morin
11/27/2008US20080292563 Inhalable Powder Containing Tiotropium
11/27/2008US20080292562 Medicaments For Inhalation Comprising Pde IV Inhibitors and Enantiomerically Pure Glycopyrrolate Salts
11/27/2008US20080292561 Pyrazolo-Pyrimidine Derivatives as Anti-Inflammatory Agents
11/27/2008US20080292558 Colored esmolol concentrate
11/27/2008US20080292553 Phosphoramidate Derivatives of Fau
11/27/2008US20080292550 Fluorinated 3'-Deoxythymidine Derivatives, a Method for Their Preparation and Their Use
11/27/2008US20080292549 High Affinity Melan-A T Cell Receptors
11/27/2008US20080292548 Compounds and methods for 18f labeled agents
11/27/2008US20080292545 Functionalized Encoded Apoferritin Nanoparticles and Processes for Making and Using Same
11/27/2008US20080290328 Photochromic Material Comprising a Proteorhodopsin Apoprotein and a Retinal Analog
11/27/2008US20080289630 Pre-metered dry powder inhaler for moisture-sensitive medicaments
11/27/2008DE202008012514U1 Verpackungseinheit zur Bereitstellung einer parenteral verabreichbaren, pharmakologisch akzeptablen pharmazeutischen Formulierung Packaging unit for providing a parenterally administrable pharmacologically acceptable pharmaceutical formulation
11/27/2008DE202008012041U1 Vaginalzäpfchen auf Basis von 3,3'-Dindolylmethan (Methindol) Vaginal suppositories based on 3,3'-Dindolylmethan (Methindol)
11/27/2008DE10251709B4 Screening-Verfahren für Wirkstoffe zur Stimulierung der humanen beta-Defensine vom Typ 2 und/oder Typ 3 Screening method for agents to stimulate the human beta-defensins type 2 and / or type 3
11/27/2008DE102007024802A1 Use of an active substance mixture comprising a fraction specific peptide and fraction essential and non-essential amino acids for the production of a composition to treat, prophylaxis and/or metaphylaxis of e.g. dementia disease
11/27/2008DE102007024470A1 New sulfoximine-substituted quinoline and/or quinazoline derivatives are erythropoietin-producing hepatoma amplified sequence-receptor kinase inhibitors useful to prepare medicaments to e.g. treat endometriosis and stenosis
11/27/2008DE102007024428A1 Use of naloxone for producing a medicament devoid of non-oral abuse-potential for humans, where the medicament contains a psychotropic substance, which is useful for treating attention deficit hyperactivity disorder
11/27/2008DE102007024138A1 Kosmetisches Hautreinigungsmittel Cosmetic skin cleanser
11/27/2008DE102007023614A1 New amide compounds used for treatment of gynecological diseases e.g. endometriosis, for female fertility control and female hormone replacement therapy, has general formula
11/27/2008DE102004019743B4 Mehrphasenpräparat zur Kontrazeption auf der Basis eines natürlichen Estrogens Multiphase product for contraception based on a natural estrogen
11/27/2008CA2724833A1 Use of seleneium yeast composition for establishing and/or maintaining pregnancy
11/27/2008CA2704111A1 Hypercompressed particles for controlled release of ophthalmic medications
11/27/2008CA2691997A1 Triazolyl aminopyrimidine compounds
11/27/2008CA2688823A1 Heterocyclic kinase modulators
11/27/2008CA2688784A1 Compositions, synthesis, and methods of using quinolinone based atypical antipsychotic agents
11/27/2008CA2688776A1 Oxo bridged diazepan orexin receptor antagonists
11/27/2008CA2688721A1 Stable pharmaceutical formulation for a dpp-iv inhibitor
11/27/2008CA2688554A1 Dose forms comprising vx-950 and their dosage regimen
11/27/2008CA2688536A1 Compositions, kits, and methods for identification, assessment, prevention, and therapy of cancer
11/27/2008CA2688267A1 Amino acid derivatives as calcium channel blockers
11/27/2008CA2688057A1 Novel case of renin inhibitors
11/27/2008CA2688008A1 Mutilin derivative having heterocyclic aromatic ring carboxylic acid structure in substituent at 14-position
11/27/2008CA2687958A1 1-substituted tetrahydroisoquinoline compound
11/27/2008CA2687957A1 Pharmaceutical containing ppar.delta. agonist
11/27/2008CA2687956A1 Method for producing pharmaceutical tablet
11/27/2008CA2687955A1 Crystalline micropowder particles
11/27/2008CA2687944A1 Spirocyclic quinazoline derivatives and their use as pde7 inhibitors
11/27/2008CA2687878A1 Antiviral agents
11/27/2008CA2687679A1 Novel compositions comprising a phosphodiesterase-5 inhibitor and their use in methods of treatment
11/27/2008CA2687647A1 Tenofovir disoproxil hemi-fumaric acid co-crystal
11/27/2008CA2687630A1 Self-emulsifying formulation of tipranavir for oral administration
11/27/2008CA2687611A1 Novel sulphoximine-substituted quinoline and quinazoline derivatives as kinase inhibitors
11/27/2008CA2687558A1 Oral preparation comprising specific organic acid, and method for improvement in elution property and chemical stability of oral preparation
11/27/2008CA2687535A1 Phosphate-modified oligonucleotide analogs with enhanced immunostimulatory activity
11/27/2008CA2687528A1 Trans-4-{2-[4-(2,3-dichlorophenyl)-piperazin-1-yl]-ethyl}-n,n-dimethylcarbamoyl-cyclohexylamine for treating acute mania
11/27/2008CA2687521A1 Use of trans-4-{2-[4-(2,3-dichlorophenyl)-piperazin-1-yl]-ethyl}-n,n-dimethylcarbamoyl-cyclohexylamine for treating schizophrenia
11/27/2008CA2687474A1 Triazolyl aminopyrimidine compounds
11/27/2008CA2687426A1 Prevention of acute kidney injury
11/27/2008CA2687415A1 Bicyclosulfonyl acid (bcsa) compounds and their use as therapeutic agents
11/27/2008CA2687338A1 Bicyclic heteroaromatic compounds as inhibitors of stearoyl-coenzyme a delta-9 desaturase
11/27/2008CA2687324A1 Combination comprising pyrrolidone-5-carboxylic acid and at least one compound from citrulline, arginine and asparagine, and use thereof in the treatment of atopic dermatitis
11/27/2008CA2687289A1 A medicament comprising a carbostyril derivative and donepezil for treating alzheimer's disease
11/27/2008CA2687283A1 Quinazolin-oxime derivatives as hsp90 inhibitors
11/27/2008CA2687209A1 Process for the preparation of form a of tegaserod
11/27/2008CA2687160A1 Spiroindolinone derivatives
11/27/2008CA2687154A1 Composition useful for the prevention of the adverse effect due to the use of ppar-gamma agonists
11/27/2008CA2686953A1 Benzamides useful as s1p receptor modulators
11/27/2008CA2686951A1 Diacylglycerol acyltransferase inhibitors
11/27/2008CA2686851A1 Fused-ring heterocycle opioids
11/27/2008CA2686675A1 3,3-spiroindolinone derivatives
11/27/2008CA2686485A1 Purinones and 1h-imidazopyridinones as pkc-theta inhibitors
11/27/2008CA2686421A1 P38.alpha. as a therapeutic target in bladder carcinoma
11/27/2008CA2686348A1 Bactericidal anti-mrsa active pharmaceutical composition containing carbapenems
11/27/2008CA2686286A1 Transdermal delivery devices assuring an improved release of an active principle through a biological interface
11/27/2008CA2686267A1 Process for the preparation of compositions for modulating a kinase cascade and methods of use thereof
11/27/2008CA2686137A1 Improved depot formulations
11/27/2008CA2686016A1 Quinoline derivatives as pi3 kinase inhibitors
11/27/2008CA2685942A1 Spiroindalones
11/27/2008CA2685858A1 Di-substituted amides for enhancing glutamatergic synaptic responses
11/27/2008CA2685826A1 Prokinetic agent for bowel preparation
11/27/2008CA2685606A1 Use of pimavanserin in the treatment of parkinson and symptoms thereof
11/27/2008CA2685318A1 5-(aminoazacyclyl)-3-sulfonyl-1h-indazoles as 5-hydroxytryptamine-6 ligands for the treatment of cns disorders
11/27/2008CA2685186A1 Methods for using vasopressin antagonists with anthracycline chemotherapy agents to reduce cardiotoxicity and/or improve survival
11/27/2008CA2685112A1 Triazol compounds for treating biofilm formation
11/27/2008CA2684945A1 Germline polymorphisms in the angiogenic pathway predict tumor recurrence in cancer therapy
11/27/2008CA2684920A1 Methods of treating cognitive disorders by inhibition of gpr12
11/27/2008CA2684879A1 Methods of identifying genes involved in memory formation using small interfering rna (sirna)
11/27/2008CA2684764A1 Aryloazol-2-yl cyanoethylamino compounds, method of making and method of using thereof
11/27/2008CA2684692A1 Use of 4-(pyrrolidin-1-yl)quinoline compounds to kill clinically latent microorganisms
11/27/2008CA2684604A1 Methods and compositions for treating skin conditions
11/27/2008CA2684150A1 Induction of a physiological dispersion response in bacterial cells in a biofilm
11/27/2008CA2684046A1 Treatment of allergic disease with immunomodulator compounds
11/27/2008CA2683350A1 Nitrogenous heterocyclic compounds, preparation thereof and use thereof a antibacterial medicaments
11/27/2008CA2683276A1 Ziprasidone formulations
11/27/2008CA2683020A1 Oral dosage form providing fast absorption of drug
11/27/2008CA2680433A1 Novel composition based on cholest-4-ene-3-one oxime
11/27/2008CA2677743A1 Lotion composition for personal use
11/27/2008CA2654877A1 Stable elsamitrucin salts suitable for pharmaceutical formulations
11/26/2008EP1995249A1 Camptothecin derivatives and their use
11/26/2008EP1995246A1 Nitrogenated heterocyclic derivative, and pharmaceutical agent comprising the derivative as active ingredient
1 ... 2978 2979 2980 2981 2982 2983 2984 2985 2986 2987 2988 2989 2990 2991 2992 2993 2994 2995 2996 2997 2998 ... 7860